Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01114360Phase 2Completed
Phase 2, randomised, double-blind trial in hypertension (HTN) comparing Melatonin with Placebo (2 arms). Primary endpoints: Mean Nighttime Systolic Blood Pressure at 4 weeks and Mean Nighttime Diastolic Blood Pressure at 4 weeks. Started Mar 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01114360.